Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q1 2020 Results - Earnings Call Transcript

Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2020 Results Earnings Conference Call May 14, 2020 4:30 AM ET

Company Participants

Sabrina Martucci Johnson - President and CEO
John Fair - Chief Strategy Officer
Lisa Walters-Hoffert - Chief Financial Officer

Conference Call Participants

Rachel Yang - ROTH Capital
Jason Kolbert - Dawson James.
Sally Yanchus - Brookline Capital
Jim Molloy - Alliance Global
Nathan Weinstein - Aegis Capital

Operator

Welcome to the conference call hosted by Daré Bioscience to review the Company's Financial Results for the Quarter Ended March 31, 2020, and to provide a general business update. This call is being recorded. My name is Victor, and I will be your operator today. With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Daré's Chief Strategy Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer.

Ms. Johnson, please proceed.

Sabrina Martucci Johnson

Thank you, and welcome to our financial results and business update call for Daré Bioscience. We are looking forward to discussion our first quarter results and highlighting the recent development and anticipated milestones for 2020 and beyond.

Before we begin, I'd like to remind you that today's discussion will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Any statements made during this call that are not statements of historical fact should be considered forward-looking statements. Actual results or events could differ materially from those anticipated or implied by these statements due to known and unknown risks and uncertainties. You should not place undue reliance on forward-looking statements.

Forward-looking statements are qualified in their entirety by the cautionary statements in the company's SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2019, which was